Fanwood, NJ, United States of America

Dennis J Sawchuk

This inventor holds 4 USPTO granted patents and 8 published patent applications and 5 EPO patents. Top assignee: Chromocell Corporation. Active years: 2014-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dennis J Sawchuk. Retrieved from https://idiyas.com/inventor/dennis-j-sawchuk

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 4 

% Patents Active = 25.0

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Hoboken, NJ (US) (2014 - 2017)
  • Fanwood, NJ (US) (2015 - 2017)

Company Filing History:


Years Active: 2014-2017

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Dennis J. Sawchuk: Innovator in Cell Fate Modulation

Introduction

Dennis J. Sawchuk is a notable inventor based in Fanwood, NJ (US). He has made significant contributions to the field of biotechnology, particularly in the area of cell fate modulation. With a total of 4 patents to his name, Sawchuk's work has implications for various applications in medical and research settings.

Latest Patents

One of his latest patents is titled "Methods and compositions for identifying and validating modulators of cell fate." This invention provides compositions and methods for identifying and validating modulators of cell fate, including maintenance, cell specification, cell determination, induction of stem cell fate, cell differentiation, cell dedifferentiation, and cell trans-differentiation. The invention relates to reporter nucleic acid constructs, host cells comprising such constructs, and methods using these cells and constructs. Additionally, it includes methods for making cells that incorporate one or more reporter nucleic acid constructs using fluorogenic oligonucleotides, which are applicable in high throughput screens.

Another significant patent is "Cell lines expressing ENaC and methods using them." This patent discloses cell lines that stably express the epithelial sodium channel (ENaC) and methods for utilizing these cell lines. The invention encompasses cell lines that express various subunit combinations and proteolyzed isoforms of ENaC, along with techniques for creating these cell lines. The ENaC-expressing cell lines are noted for their high sensitivity, physiological relevance, and consistent results.

Career Highlights

Dennis J. Sawchuk is currently associated with Chromocell Corporation, where he continues to advance his research and innovations. His work has been instrumental in developing technologies that enhance our understanding of cellular processes and their applications in therapeutic contexts.

Collaborations

Throughout his career, Sawchuk has collaborated with notable colleagues, including Kambiz Shekdar and Jessica Langer. These collaborations have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

In summary, Dennis J. Sawchuk is a prominent inventor whose work in cell fate modulation has led to significant advancements in biotechnology. His patents reflect a commitment to innovation and a deep understanding of cellular mechanisms, making him a valuable contributor to the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…